Evidence map›Paper›PMID 19573617›Full record

ReviewMicrobes and infection2009

Role of Nod2 in the development of Crohn's disease.

Soichiro Yamamoto, Xiaojing Ma

Abstract readReview
In one paragraph

Review in Microbes and infection, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Controversies in the Relationship BetweenJournal of clinical medicine · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. Structure-activity relationship in NOD2 agonistic muramyl dipeptides.European journal of medicinal chemistry · 2024
    Review
  11. Article
  12. Review
  13. Microbial cues stimulate linear growth in undernourished mice.Nature reviews. Gastroenterology & hepatology · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Soichiro YamamotoDepartment of Microbiology and Immunology, Weill Medical College of Cornell University 1300 York Avenue, New York, NY 10021, USA.
Xiaojing Ma

Funding

Crohn's disease-associated NOD2 MutantsR01AI072149 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI MA, XIAOJING · 2009 to 2010
$857k
NIAID NIH HHS R01 AI072149
6 · The paper itself

Abstract

Crohn's Disease (CD) is caused by a loss of the regulatory capacity of the immune apparatus. Nod2 is an intracellular bacterial sensor and its mutations are associated with the development of CD. Here we summarize recent and controversial findings about the role of the Nod2 mutants in the disease process.

Indexed as

Crohn DiseaseCytokinesHumansInflammationMacrophagesModels, BiologicalMonocytesMutant ProteinsNod2 Signaling Adaptor ProteinCytokinesMutant ProteinsNOD2 protein, humanNod2 Signaling Adaptor Protein

Identifiers

PMID19573617
PMCPMC2924159

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.